GlaxoSmithKline is a British pharmaceutical company headquartered in London. Established in 2000 by the merger of Glaxo Wellcome and SmithKline Beecham, GSK was the world's 6th largest pharmaceutical company as of 2015, after Pfizer, Novartis, Merck, Hoffmann-La Roche and Sanofi.ref
Climate Policy Rating: InfluenceMap A-
GlaxoSmithKline continues to support ambitious climate change, mainly in the EU. However, it is a direct member of the Confederation of British Industry, which has mixed support for climate change legislation.
See GlaxoSmithKline for a long list of Seriously Bad Stuff.
- 3.02% Vanguard Group Inc
- 2.61% BlackRock Advisors (UK) Ltd
- 2.57% BlackRock Investment Management (UK) Ltd
- 2.46% Norges Bank Investment Management
- 2.03% Legal & General Investment Management Ltd
- 1.50% Capital Research & Management Company (Global)
- 1.34% Dodge & Cox
- 1.33% Schroder Investment Management Ltd
- 1.27% Capital Research & Management Company (World)
- 1.25% Ameriprise § Threadneedle Asset Management Ltd
- Sept.2013: Ribena and Lucozade were sold to Suntory Beverage & Food Ltd, a Japanese holding company.ref,ref
- Dec.2000: GlaxoSmithKline plc: SmithKline Beecham plc and Glaxo Wellcome plc merged.ref,ref Regulatory approval required the divestment of a number of products; the most significant were: Famvir was sold to Novartis, and Kytril was sold to Roche.
SmithKline Beecham plc
- Jun.1993: Sara Lee Corporation bought the worldwide bath and body care operations; and Wella AG bought the hair-care brands, including Brylcreem men's toiletries, Badedas bubble bath and Body Mist deodorants. Wella also bought SmithKline's hair-care brands, including Silvikrin, Vosene and Bristows.ref
- AR-Dec.1991: Disposals: SBF Holdings Ltd; the Montana cosmetics and fragrances business in France; disposal of assets in a UK animal health business.
- AR-Dec.1990: Disposals: Ambrosia, Bovril, Marmite; Yardley/Lentheric and Astor/Lancaster cosmetics and fragrances business; and the Neolait/Codislait animal nutritional business in France.
- 1989: Engerix-B hepatitis B vaccine (recombinant), a genetically-engineered hepatitis B vaccine, was launched in the USA and France.
- Jul.1989: SmithKline Beecham plc: the Beecham Group plc and US company SmithKline Beckman Corporation merged, with Beecham Group plc becoming a wholly-owned subsidiary of SmithKline Beecham plc.ref,ref
Beecham Group plc
- Sept.1988: The Juvena group of cosmetics companies based principally in Europe was sold to ??
- Aug.1988: Beecham Cosmetics Inc in the USA was sold to ??
- Sept.1987: DAP Inc, the home improvement products business in the USA, was sold to ?? DAP Products
- Jan.1987: The UK softs drinks business, Corona, Tango, Quosh and Top Deck were sold to Britvic plc, leaving just Lucozade and Sparkling Ribena.ref
- Dec.1986: the UK and European home improvement products business was sold to ??
- AR-Mar.1986: Ceresit became a wholly-owned subsidiary.
- Dec.1985: Norcliff Thayer Inc, a US manufacturer and distributor of otc medicines and health products, was acquired, adding Tums (antacid tablets) and Oxy (acne treatments) to its over-the-counter portfolio.
- AR-Mar.1986: disposed of the retail milk business of Horlicks Farms and Dairies. Reached agreement on the sale of the Batchelors foods business in Ireland, and two smaller businesses in Australia and the USA. Looking for a purchaser for the Home Improvements businesses.
- 1985: BAT Industries cosmetics and fragrances business was acquired. Brands included: Yardley, Lentheric, Morny, Cyclax, Juvena, Germaine Monteil, Carven, Gres.
- Mar.1985: Unibond (Holdings) plc.
- Jan.1985: British-American Cosmetics Ltd acquisition completed. Renamed to Bond Street Cosmetics.
- Jul.1984: Copydex plc. Manufactures and sells home improvement products, including adhesives and floor covering accessories.
- Apr.1984: Roberts Consolidated Industries Inc, a supplier of branded contact adhesives in the USA.
- Apr.1984: Dr Lo ambeletti SpA, an Italian pharmaceutical company.
- ??.1982/83: Fink Group in Germany, natural health foods and medicines.
- Feb.1983: DAP Inc, a specialised home improvement products business, was acquired.
- 1983: Diane Von Furstenberg, a fragrance line, was acquired.
- Oct.1982: JB Williams, maker of Aqua Velva, Geritol, Sominex, Lectric Shave brands, was acquired by #Nabisco.
- ??.1981/82: Jil Sander, a small fragrances and cosmetics business in Germany, was acquired.
- Nov.1981: Beecham Group plc: re-registered as a public limited company.
Beecham Group Ltd
- 1981: Augmentin, an antibiotic used to treat bacterial infections, was introduced.
- Apr.1980: Bovril Group of companies was purchased.
- ?date?: Marmite, Ambrosia.
- Sept.1979: Jovan Inc, a USA manufacturer and distributor of fragrances and perfumes, was acquired.
- Aug.1978: Scott & Bowne Ltd, toiletries and proprietary medicines, in the UK.
- ?date?: Rohm & Haas, a USA animal health business. Range of animal vaccines.
- 1976/77: Beecham Laboratories: Mowatt & Moore Ltd, a private pharmaceutical company in Quebec. Subsequently renamed.
- ?date?: Haering & Company, a family-owned toiletries business in Switzerland.
- Apr.1977: Calgon: the floundering consumer and bath products line was acquired from Merck & Company Inc. Principal brands acquired were Cling Free, an anti-static fabric softener; Calgon and Calgonite, a water softener and dishwasher detergent; Calgon bath additives; Sucrets throat lozenges; Hold cough suppressant; and Fruit Fresh, a fruit preservative.
- 1977: Sucrets brand was acquired from Merck & Company Inc. In 2000, GlaxoSmithKline sold the brand to Insight Pharmaceuticals Corporation, a portfolio company of American private equity firm Swander Pace Capital and its co-investment partner, Ontario Teachers' Pension Plan.ref In Apr.2014, Insight Pharmaceuticals was acquired by Prestige Brands Holdings Inc.ref ,
- 1975: Johann A Wülfing KG in Germany.
- ?date?: Findlater, Mackie, Todd, a wine and spirits subsidiary.
- Jan.1974: Lingner & Fischer GmbH, based in West Germany, was acquired. Main products are toiletries, including Odol mouthwash.
- ?date?: Fischer & Fischer: German company, markets the Badedas range of bath products.
- Dec.1973: Laboratoires Neolait SA, a private company based in Britttany, acquired a 77.8% interest.
- Dec.1973: Batchelors Ltd, an Ireland-based food and soft drinks company, was acquired.
- Apr.1973: Laboratorios Villela SA, a Brazilian pharmaceutical company.
- 1973: Aqua-fresh toothpaste was launched.
- 1971: SE Massengill Company, feminine hygiene products, was acquired.
- ?date?: Silvikrin shampoo.
- ?date?: Vosene, made by the Vosemar Company of Bury, Lancashire, was acquired. Website
- 1969: Shloer apple and grape drinks was acquired. Vosene.co.uk, Lornamead.com
- 1969: Horlicks Ltd, created in 1843 by brothers William and James Horlick, was acquired.ref,ref
- 1959: Penicillin: Beecham scientists discovered the penicillin nucleus;ref the discovery enabled the synthesis of a nmber of new semisynthetic penicillins: Broxil (phenethicillin); Celbenin (methicillin); Penbritin (ampicillin); Amoxil (amoxicillin).
- 1957 (1954?): Corona: Thomas & Evans Ltd, manufacturer of Corona soft drinks, was acquired. Corona (soft drink)
- 1955: Ribena: HW Carter & Company, manufacturer of the syrup, was acquired. The name was supposedly derived from the Latin for blackcurrant: "Ribes nigrum". ref,ref
- 1949: CL Bencard Ltd, a manufacturer of allergy vaccines, was acquired.
- Aug.1945: Beecham Group Ltd: the company was re-named.
Beecham's Pills Ltd
- 1943: Beecham Research Laboratories Ltd was opened in Brockham Park, Surrey to focus exclusively on basic pharmaceutical research.
- 1939: Brylcreem: County Perfumery Company Ltd, manufacturers of Brylcreem, a men's hair application, was acquired, adding products for men to its product line.
- 1938: Eno Proprietaries Ltd, manufacturer of the antacid Eno's Fruit Salts, was acquired.ref:253 The deal provided Beecham's with 14 subsidiaries in the Americas, South Africa, Australia, New Zealand and western Europe.ref James Crossley Eno
- 1938: Macleans Ltd, manufacturer of toothpaste, was acquired. Macleans was founded in 1919 by Alex C Maclean to produce 'own-brand' products for chemists.
- 1938: Lucozade, the glucose drink then known as "Glucozade", was acquired from its inventor, William Walker Hunter.ref
- late.1930s: Prichard and Constance, a shampoo manufacturer that distributed the brand name Amami, was acquired.
- Jan.1928: Beecham's Pills Ltd was incorporated as a public company.
- 1928: Veno Drug Company, a Manchester-based manufacturer of cough syrup, was acquired.
- 1926: Beecham's Powders, a cold remedy, was introduced.
- 1924: Philip Hill, a financier who had made his money in real estate, acquired control of Beecham.
- 1859: The first factory in St Helens, Lancashire, was opened to speed up production of medicines.
- 1847: Beecham Pills: Thomas Beecham sold his pills from a market stall in Wigan.ref
- 1842: Beecham's Pills, a mild laxative comprised of aloes, ginger and soap, was Thomas Beecham's first product.
- Thomas Beecham, a chemist, ...
- Dec.20.2018: Pfizer deal paves way for Glaxo break-up. Britain’s biggest drugs company struck a landmark deal yesterday with a leading American rival that prepares the way for the break-up of GlaxoSmithKline. Glaxo agreed to merge its consumer healthcare division with Pfizer's through a joint venture which will be the world’s biggest over-the-counter medicines business. Glaxo also plans to demerge the business within 3 years of the deal closing in the second half of next year through a separate British stock market listing, which would create a new FTSE 100 company valued in the region of £40bn. The Guardian, Alex Ralph, Martin Strydom.
- Dec.04.2018: Glaxo drug deal fails to tempt City. GSK has agreed to buy Tesaro. ...determined to rebuild its cancer drugs portfolio. It also agreed to sell its consumer nutrition business to Unilever. The sale followed a review after it bought out Novartis, its consumer healthcare partner, in March. The Times, Alex Ralph.
- GSK reaches agreement with Novartis to acquire full ownership of its Consumer Healthcare Business, https://www.gsk.com/en-gb/investors/
- Feb.05.2014: GlaxoSmithKline hails drug pipeline after 2013's China scandal. GSK, one of the UK's largest companies, announced it had 10 promising drugs and vaccines in late-stage development. Chinese authorities have accused GSK of being a "criminal godfather", running a £320m slush fund to bribe doctors and hospital officials with cash payments and visits to prostitutes, in order to sell its products. GSK has reported itself to the Serious Fraud Office, as well as the US Department of Justice and the Securities and Exchange Commission, but said on Wednesday it was unable to estimate the final bill for the China scandal. GSK's chief executive Andrew Witty said GSK expected to increase investment in its two Scottish factories in Montrose and Irvine, in the coming years. He also batted away concerns about volatility in emerging markets, following recent currency turbulence in Argentina, Indonesia and Turkey. "The core fundamentals" of emerging markets, he said, citing their growing population, rising per-capita incomes and increasing demand for healthcare, all played well with GSK. The Guardian, Jennifer Rankin.
- The A-List of Climate Policy Engagement. Which global companies lead in strategic lobbying for the ambitions of Paris? Rankings measure how a corporation or trade association behaves towards 2°C aligned climate and energy policy. Influence Map. Apr.2018
- GlaxoSmithKline: InfluenceMap Report. InfluenceMap. Accessed Oct.10.2018.
- Corporate Political Engagement Index 2018. The new index of 104 multi-national companies, many of whom regularly meet with govt, has found nearly 75% are failing to adequately disclose how they engage with politicians. Only one company received the highest grade, with the average grade being "E" – representing poor standards in transparency. Transparency International UK. Nov.2018